Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2021-07-30 2021-04-07
Drug Identification Number 02465086 02465086
Brand name JAMP-RIZATRIPTAN ODT JAMP-RIZATRIPTAN ODT
Common or Proper name Rizatriptan Tablets Rizatriptan Tablets
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients RIZATRIPTAN RIZATRIPTAN
Strength(s) 5MG 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 6 6
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2020-10-01 2020-10-01
Estimated end date 2021-04-30
Actual end date 2021-05-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments